Friday, August 7, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP InternationalTrade Show
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP InternationalTrade Show
Fiinews
No Result
View All Result
Home Manufacturing

India urged to be a world leader in pharma supplies

Fiinews by Fiinews
March 25, 2020
in Manufacturing
Reading Time: 2 mins read
A A
0
Pfizer
0
SHARES
10
VIEWS
LinkedinShare on Twitter

Threat of over dependence on China, warns Sridhar

India needs to be a World leader for not just Generic formulations but APIs (active pharmaceutical ingredients) too, according to S Sridhar, Chair, FICCI Pharmaceuticals Committee and MD, Pfizer.

India’s pharmaceutical import dependence on China, nearly 70% by value, has become a significant threat to the local healthcare manufacturing and global supply chain, Sridhar warned in a message welcoming the Government’s decision on Bulk Drug Parks.

While Indian pharma companies over years have climbed up the value chain to focus on value-added formulations, but this over dependence on China has increased the threat to the nation’s health security as some of these critical and complex APIs are crucial to address India’s growing disease burden.

India should not look at these Bulk Drug Parks only for Domestic requirement. China became big supplier because of scale which looked into both domestic and export requirement, he pointed out.

“Domestic (market) will not give scale and is always exposed to cost and pricing pressures. With this new policy initiative, the Government must look at incentivising the manufacturing of the critical 54 APIs which were recently restricted for exports,” he said on 22 Mar 2020.

He called on the Government and the Industry to work together for not just domestic capacities but fulfilling global export demands too.

The Indian pharma industry has been a world leader in generics markets contributing significantly to the global demand for generics in terms of volume.

‘Made in India’ drugs supplied to the developed economies such as the US, EU, Japan and many other countries are known for their safety and quality, he noted.

The Government is promoting Bulk Drug Parks for financing Common Infrastructure facilities in 3 Bulk Drug Parks with financial implication of Rs.3,000 crore over next 5 years to boost domestic manufacturing of critical KSMs/Drug Intermediates and APIs.

Welcoming the Government decision, he assured wide support from FICCI and its pharma member companies. fiinews.com

Tags: FICCIPfizer
ShareTweetShare

Related Posts

Startup Policy Forum
Manufacturing

Manufacture: Startup-Semicon alliance launched

by Fiinews
August 6, 2026
0
16

Krishnan says India's semiconductor journey requires strong partnerships between government and stakeholders Startup Policy Forum (SPF) has launched ‘The Semicon...

NTPC.
Manufacturing

Manufacture: Rs.1,983.67cr revenue from 6 blocks

by Fiinews
August 6, 2026
0
13

Ministry expects Rs.1,743cr investment from recently auctioned coal concessions The six coal blocks auctioned in April 2026 are poised to...

Coal India Ltd

Manufacture: 302.24 MT coal produced in FY2026-27

August 4, 2026
26
Monolithisch

Manufacture: Monolithisch to put plant on dry run

July 28, 2026
18
Caelux

Manufacture: Navitas-Caelux to make solar modules

July 28, 2026
19
Kaisemi

Manufacture: KaiSemi plans India expansion

July 19, 2026
19
SBI YONO
Upits 2026 brochure 062026 pdf

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Investment: India welcomes US investment and technology collaboration

    0 shares
    Share 0 Tweet 0
  • Market: PM Modi-President Zelenskyy discussed trade and technology

    0 shares
    Share 0 Tweet 0
  • Manufacturing: Approved ‘BioE3’of Biotechnology Dept

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Tender: Guwahati-Tezpur Corridor approved
  • Invest: KKR to acquire 4,800-bed hospital group
  • Invest: Vasuki raises Rs.100cr from single NRI
  • Market: India needs world-class expo hubs
  • Manufacture: Startup-Semicon alliance launched

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP International

© 2024 FIINEWS - Design and developed by 7clicksmedia.